Target intelligence / Profile preview

Renal function visualization

Molecular classification
Other (Imaging modality/diagnostic procedure)
01

Overview

Renal function visualization encompasses various diagnostic procedures that use medical imaging technologies—most commonly nuclear medicine techniques like renal scintigraphy—to evaluate how well the kidneys filter blood, excrete waste products, maintain structure, and receive blood supply. These tests typically involve injecting small amounts of radioactive tracers into the bloodstream; specialized cameras then detect tracer distribution within the kidneys over time. The resulting images provide unique insights into both anatomical integrity and physiological performance that cannot be obtained by standard laboratory tests alone. Advanced MRI-based methods can also noninvasively quantify tissue fibrosis or oxygenation status using parameters such as ADC values or BOLD signals. These approaches play critical roles in diagnosing acute/chronic kidney diseases, monitoring progression or response to therapy—including after transplantation—and guiding patient management decisions.

Other names
Renal scanKidney scanRenal scintigraphyKidney functional MRI
02

Mechanism of action

Not applicable for drugs targeting this entity. For radiotracers: Radiotracer accumulates in renal tissue; gamma camera detects emitted radiation for image formation. For diuretic-assisted studies: Diuretic increases urine flow to help distinguish between obstructive and non-obstructive causes.

03

Biological functions

Assessment of kidney perfusion (blood flow)Evaluation of glomerular filtration and excretory functionDetection of structural abnormalities in kidneys
04

Disease associations

Chronic kidney disease (CKD)Acute kidney injuryRenovascular disease (e.g., renal artery stenosis)Obstructive uropathyPost-transplant monitoring
05

Safety considerations

Nuclear medicine scans involve exposure to low levels of ionizing radiation.Allergic reactions can occur with some contrast agents.Caution required in patients with severe renal impairment when using iodinated contrast media for CT urography; however, most nuclear tracers are considered safe even with reduced GFR.
06

Interacting drugs

Technetium-labeled agents

2 more in the full profile.

07

Biomarkers

Apparent diffusion coefficient (ADC) from diffusion-weighted MRI—correlates with fibrosis severity in CKDTotal kidney volume on structural MRI—used especially in polycystic kidney disease prognosis

Beyond the preview

Go deeper on Renal function visualization.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renal function visualization.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call